Literature DB >> 2206942

Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer.

Y Tomita1, T Nishiyama, M Fujiwara, S Sato.   

Abstract

In order to investigate the anti-tumour immune responsiveness of patients with renal cell cancer (RCC), we examined 30 such patients for the degree of expression of major histocompatibility complex (MHC) class I and class II antigens on RCC and the populations of tumour-infiltrating mononuclear cells (TIM). Normal renal tubular cells expressed class I but not class II antigens. Most of the tumour cells expressed class I antigens in 25 (83%) cases, but the proportion of such cells was reduced in five cases, three of which were of granular cell type histologically. Class II antigens were detected in all specimens with class I positivity. Various numbers of TIM were detected in 25 cases, being composed mainly of T cells and a smaller number of macrophages. Examination for the phenotype of T cells showed that CD8-positive cells were the dominant population. B cells were not detected. Quantitative analysis revealed that the numbers of TIM were significantly lower in cases showing class I reduction than in those with normal class I expression. Therefore, it was clear that class I antigens were preserved in RCC cells in most cases. Furthermore, a higher rate of reduction of class I antigens was observed in cases of granular cell type, which has been reported to have a worse prognosis than the clear cell type. The present data suggest that degree of the expression of MHC class I antigen on RCC might influence the host immune responsiveness against it.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206942      PMCID: PMC1971437          DOI: 10.1038/bjc.1990.296

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.

Authors:  K Sakai; M Takiguchi; S Mori; O Kobori; Y Morioka; H Inoko; M Sekiguchi; K Kano
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

2.  YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.

Authors:  G E Piontek; K Taniguchi; H G Ljunggren; A Grönberg; R Kiessling; G Klein; K Kärre
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

3.  B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.

Authors:  F Momburg; B Herrmann; G Moldenhauer; P Möller
Journal:  Int J Cancer       Date:  1987-11-15       Impact factor: 7.396

4.  Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.

Authors:  F Momburg; T Degener; E Bacchus; G Moldenhauer; G J Hämmerling; P Möller
Journal:  Int J Cancer       Date:  1986-02-15       Impact factor: 7.396

5.  Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy.

Authors:  P Möller; B Herrmann; G Moldenhauer; F Momburg
Journal:  Int J Cancer       Date:  1987-07-15       Impact factor: 7.396

6.  A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Authors:  S A Rosenberg; M T Lotze; L M Muul; A E Chang; F P Avis; S Leitman; W M Linehan; C N Robertson; R E Lee; J T Rubin
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

7.  A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.

Authors:  S A Rosenberg; P Spiess; R Lafreniere
Journal:  Science       Date:  1986-09-19       Impact factor: 47.728

8.  Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.

Authors:  A Belldegrun; L M Muul; S A Rosenberg
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

9.  HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.

Authors:  H F van den Ingh; D J Ruiter; G Griffioen; G N van Muijen; S Ferrone
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

10.  Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomas.

Authors:  D Heinemann; P J Smith; M O Symes
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

View more
  10 in total

1.  Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.

Authors:  K Höbarth; A Hallas; G Steiner; A Gomahr; W Aulitzky; M Marberger
Journal:  Urol Res       Date:  1996

2.  HLA expression and tumor-infiltrating immune cells in uveal melanoma.

Authors:  I de Waard-Siebinga; C G Hilders; B E Hansen; J L van Delft; M J Jager
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

3.  CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival.

Authors:  Jonathan M Weiss; W Gregory Alvord; Octavio A Quiñones; Jimmy K Stauffer; Robert H Wiltrout
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

4.  Expression of intercellular adhesion molecule-1 on transitional cell cancer. Possible significance in immunity against tumor cells.

Authors:  Y Tomita; H Watanabe; H Kobayashi; T Nishiyama; S Tsuji; K Imai; T Abo; M Fujiwara; S Sato
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

5.  Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.

Authors:  Y Tomita; H Watanabe; H Kobayashi; T Nishiyama; S Tsuji; M Fujiwara; S Sato
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma.

Authors:  D Mitropoulos; S Kooi; J Rodriguez-Villanueva; C D Platsoucas
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

7.  Defective major histocompatibility complex class I expression in a sarcomatoid renal cell carcinoma cell line.

Authors:  M K Jakobsen; N P Restifo; P A Cohen; F M Marincola; L B Cheshire; W M Linehan; S A Rosenberg; R B Alexander
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1995-05

8.  Immunohistochemical detection of P-glycoprotein and GSTP1-1 in testis cancer.

Authors:  A Katagiri; Y Tomita; T Nishiyama; M Kimura; S Sato
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

9.  Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder.

Authors:  T Imai; M Kimura; M Takeda; Y Tomita
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

10.  Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma.

Authors:  T Saito; M Kimura; T Kawasaki; S Sato; Y Tomita
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.